We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Mondelez International
MDLZ
$80.5B
| $96.7M | 0.28% |
2,678,431
-37,449
| -1% | -$1.35M |
|
77
Kinder Morgan
KMI
$70.5B
| $96.1M | 0.28% |
2,283,719
+239,419
| +12% | +$9.91M |
|
78
Occidental Petroleum
OXY
$55.6B
| $92.2M | 0.27% |
1,265,015
-27,817
| -2% | -$2.15M |
|
79
HP
HPQ
$24.6B
| $91.9M | 0.27% |
6,493,220
-115,011
| -2% | -$1.9M |
|
80
Danaher
DHR
$138B
| $90.1M | 0.26% |
1,579,758
-30,575
| -2% | -$1.75M |
|
|
MON
81
DELISTED
Monsanto Co
MON
| $89M | 0.26% |
791,057
-27,336
| -3% | -$3.25M |
|
82
Lockheed Martin
LMT
$132B
| $88.1M | 0.25% |
434,236
-2,629
| -0.6% | -$519K |
|
83
DuPont de Nemours
DD
$18.7B
| $87.2M | 0.25% |
718,011
-7,728
| -1% | -$917K |
|
84
Target
TGT
$65.6B
| $87.2M | 0.25% |
1,062,819
-10,588
| -1% | -$818K |
|
|
KRFT
85
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $85M | 0.25% |
976,196
-16,350
| -2% | -$1.08M |
|
86
General Motors
GM
$80B
| $84.9M | 0.25% |
2,265,185
+1,083
| +0% | +$39.4K |
|
87
Morgan Stanley
MS
$330B
| $84.6M | 0.24% |
2,370,389
-25,935
| -1% | -$931K |
|
88
Duke Energy
DUK
$98.4B
| $84.6M | 0.24% |
1,101,607
-17,474
| -2% | -$1.42M |
|
89
McKesson
MCK
$101B
| $84M | 0.24% |
371,468
-9,173
| -2% | -$2.03M |
|
90
TJX Companies
TJX
$176B
| $83.1M | 0.24% |
2,371,366
-70,956
| -3% | -$2.42M |
|
|
EMC
91
DELISTED
EMC CORPORATION
EMC
| $82M | 0.24% |
3,206,388
-39,151
| -1% | -$1.08M |
|
92
MetLife
MET
$62.5B
| $80.6M | 0.23% |
1,788,080
-16,584
| -0.9% | -$745K |
|
93
EOG Resources
EOG
$77.5B
| $80.4M | 0.23% |
877,401
-15,795
| -2% | -$1.43M |
|
94
Blackrock
BLK
$170B
| $79M | 0.23% |
216,045
-12,333
| -5% | -$4.47M |
|
95
Thermo Fisher Scientific
TMO
$214B
| $78.6M | 0.23% |
584,787
-985
| -0.2% | -$127K |
|
96
PNC Financial Services
PNC
$99.2B
| $76.2M | 0.22% |
816,800
-13,840
| -2% | -$1.25M |
|
97
FedEx
FDX
$73B
| $73.4M | 0.21% |
443,810
-6,195
| -1% | -$1.08M |
|
98
NextEra Energy
NEE
$183B
| $73.3M | 0.21% |
2,817,292
-23,080
| -0.8% | -$609K |
|
99
Automatic Data Processing
ADP
$105B
| $72M | 0.21% |
841,223
-31,379
| -4% | -$2.7M |
|
|
BNY
100
Bank of New York Mellon
BNY
$106B
| $71.4M | 0.21% |
1,774,506
-25,147
| -1% | -$979K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.